DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Tanizawa Y, Kaku K, Araki E. et al.
Long-term safety and efficacy of tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, as monotherapy or in combination with other oral antidiabetic agents in Japanese patients with type 2 diabetes mellitus: Multicenter, open-label, randomized controlled trials.
Expert Opin Pharmacother 2014;
15: 749-766
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.